Product NDC: | 53489-281 |
Proprietary Name: | Ergoloid Mesylates |
Non Proprietary Name: | Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-ergocryptine mesylate, and Dihydro-.beta.-ergocryptine mesylate |
Active Ingredient(s): | .222; .111; .333; .333 mg/1; mg/1; mg/1; mg/1 & nbsp; Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-ergocryptine mesylate, and Dihydro-.beta.-ergocryptine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53489-281 |
Labeler Name: | Mutual Pharmaceutical Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA081113 |
Marketing Category: | ANDA |
Start Marketing Date: | 19911031 |
Package NDC: | 53489-281-03 |
Package Description: | 250 TABLET in 1 BOTTLE, PLASTIC (53489-281-03) |
NDC Code | 53489-281-03 |
Proprietary Name | Ergoloid Mesylates |
Package Description | 250 TABLET in 1 BOTTLE, PLASTIC (53489-281-03) |
Product NDC | 53489-281 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-ergocryptine mesylate, and Dihydro-.beta.-ergocryptine mesylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19911031 |
Marketing Category Name | ANDA |
Labeler Name | Mutual Pharmaceutical Company, Inc. |
Substance Name | DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE; DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE; DIHYDROERGOCORNINE MESYLATE; DIHYDROERGOCRISTINE MESYLATE |
Strength Number | .222; .111; .333; .333 |
Strength Unit | mg/1; mg/1; mg/1; mg/1 |
Pharmaceutical Classes |